Form 4: Guardant Health Director Tariq Musa Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Director Tariq Musa reported the disposition of 249 shares of Common Stock and 249 Restricted Stock Units of Guardant Health, Inc. on March 15, 2025.

Summary

  • On March 15, 2025, Tariq Musa, a director of Guardant Health, Inc., reported a transaction involving the disposition of 249 shares of Common Stock.
  • The transaction was related to the vesting of Restricted Stock Units (RSUs).
  • Following the reported transaction, Musa directly owns 3,327 shares of Common Stock.
  • Musa also directly owns 5,997 derivative securities (Restricted Stock Units).

Sentiment

Score: 5

Explanation: This is a routine filing related to stock transactions by a company director, and it doesn't inherently indicate positive or negative sentiment. It's a neutral disclosure.

Industry Context

This is a standard SEC Form 4 filing, reflecting a corporate insider's stock transactions. Such filings are common and provide transparency into the trading activities of company directors and officers.

Stakeholder Impact

  • The transaction has a minimal impact on shareholders as it reflects routine stock vesting.

Key Dates

DateDescription
03/06/2023Date the restricted stock units were granted, vesting over a four-year period.
03/15/202325% of the shares subject to the restricted stock units vested on the one-year anniversary of this date.
03/15/2025Date of the reported transaction where 249 shares of Common Stock were disposed of due to RSU vesting.
03/18/2025Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.